MYCOF(MYCOF)
MYCOF
No analyst ratings available
No analyst price targets available for MYCOF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $112,290 | $12M | $107M |
| Low | $112,290 | $12M | $107M |
| High | $112,290 | $12M | $107M |
| EBITDA Avg | $67,374 | $7M | $64M |
| Low | $67,374 | $7M | $64M |
| High | $67,374 | $7M | $64M |
| EBIT Avg | $67,374 | $7M | $64M |
| Low | $67,374 | $7M | $64M |
| High | $67,374 | $7M | $64M |
| Net Income Avg | $-277M | $-259M | $199M |
| Low | $-277M | $-259M | $199M |
| High | $-277M | $-259M | $199M |
| EPS Avg | $-224.58 | $-209.55 | $160.74 |
| Low | $-224.58 | $-209.55 | $160.74 |
| High | $-224.58 | $-209.55 | $160.74 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $340,535 | $340,535 | $340,535 | $1M | $3M | $7M |
| Low | $340,535 | $340,535 | $340,535 | $1M | $3M | $7M |
| High | $340,535 | $340,535 | $340,535 | $1M | $3M | $7M |
| EBITDA Avg | $204,321 | $204,321 | $204,321 | $661,699 | $2M | $4M |
| Low | $204,321 | $204,321 | $204,321 | $661,699 | $2M | $4M |
| High | $204,321 | $204,321 | $204,321 | $661,699 | $2M | $4M |
| EBIT Avg | $204,321 | $204,321 | $204,321 | $661,699 | $2M | $4M |
| Low | $204,321 | $204,321 | $204,321 | $661,699 | $2M | $4M |
| High | $204,321 | $204,321 | $204,321 | $661,699 | $2M | $4M |
| Net Income Avg | $-910M | $-444M | $-901M | $-875M | $-814M | $-832M |
| Low | $-910M | $-444M | $-901M | $-875M | $-814M | $-832M |
| High | $-910M | $-444M | $-901M | $-875M | $-814M | $-832M |
| EPS Avg | $-57.35 | $-27.99 | $-56.76 | $-55.14 | $-51.32 | $-52.39 |
| Low | $-57.35 | $-27.99 | $-56.76 | $-55.14 | $-51.32 | $-52.39 |
| High | $-57.35 | $-27.99 | $-56.76 | $-55.14 | $-51.32 | $-52.39 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |